Novelos Therapeutics Announces Leadership Transition

Therapeutics, Inc. , a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that Harry , the company's President and CEO and a Director, will step down from his positions with the company, in order to pursue other opportunities, upon the naming of his successor.

http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=24073